Skip to main content
. 2020 Jun 21;57:102830. doi: 10.1016/j.ebiom.2020.102830

Fig. 5.

Fig. 5

Measurement of HIV-1-specific antibodies.

Plasma samples before initiation of cART and after 5 years of cART were tested for HIV-1-specific antibody levels using a detuned version of the HIV-1 VITROS assay (a) and a limiting antigen avidity assay (b). The dotted line represents the HIV-1 antibody assay diagnostic cut-off level used to classify individuals as HIV-1-positive or -negative. The p-values between groups were assessed using the Mann-Whitney test.